48 participants
Biweekly Schedule of Docetaxel and Cisplatin in High Risk Patients With Unresectable Non-small Cell Lung Cancer (NSCLC)
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2014-03-03
- Start Date:
- 2009-10-31
- Completion:
- 2012-08-31
Conditions
- Non-small Cell Lung Cancer
Interventions
- DRUG